Associations of NKX2-5 Genetic Polymorphisms with the Risk of Congenital Heart Disease: A Meta-analysis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27033241)

Published in Pediatr Cardiol on March 31, 2016

Authors

Xiaochuan Xie1, Xiaohan Shi2, Xiaoshuang Xun3, Li Rao4

Author Affiliations

1: Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
2: Division of Reproductive Medical Center, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
3: West China School of Public Health, Sichuan University, Chengdu, Sichuan, China.
4: Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. raoli8991@163.com.

Articles cited by this

The incidence of congenital heart disease. J Am Coll Cardiol (2002) 16.13

GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature (2003) 6.40

Mutations in NOTCH1 cause aortic valve disease. Nature (2005) 6.27

Congenital heart disease in 56,109 births. Incidence and natural history. Circulation (1971) 5.55

Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet (1997) 5.11

Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation (2007) 4.34

Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet (2011) 3.82

Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet (2001) 3.14

Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest (1999) 2.95

Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell (2004) 2.64

Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr (1989) 2.55

The changing epidemiology of congenital heart disease. Nat Rev Cardiol (2010) 1.99

Iroquois homeobox gene 3 establishes fast conduction in the cardiac His-Purkinje network. Proc Natl Acad Sci U S A (2011) 1.92

Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest (2004) 1.80

The adult with congenital heart disease: born to be bad? J Am Coll Cardiol (2005) 1.72

Nkx2.5 homeoprotein regulates expression of gap junction protein connexin 43 and sarcomere organization in postnatal cardiomyocytes. J Mol Cell Cardiol (2003) 1.67

Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation (2003) 1.45

Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases. Pharmacol Ther (2005) 1.42

Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet (2003) 1.42

Mortality in adult congenital heart disease. Eur Heart J (2010) 1.40

NKX2-5: an update on this hypermutable homeodomain protein and its role in human congenital heart disease (CHD). Hum Mutat (2010) 1.21

Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation. Cardiovasc Res (2011) 1.08

Analyses of GATA4, NKX2.5, and TFAP2B genes in subjects from southern China with sporadic congenital heart disease. Cardiovasc Pathol (2012) 1.04

Congenital heart malformations: prevalence, severity, survival, and quality of life. Cardiol Young (2000) 1.04

Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease. Clin Genet (2010) 0.97

Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica (2010) 0.94

Genetic origins of pediatric heart disease. Pediatr Cardiol (2009) 0.92

A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden death. Clin Chim Acta (2010) 0.91

Genetic and functional analysis of the NKX2-5 gene promoter in patients with ventricular septal defects. Pediatr Cardiol (2012) 0.86

Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis. Gene (2013) 0.84

Screening NKX2.5 mutation in a sample of 230 Han Chinese children with congenital heart diseases. Genet Test Mol Biomarkers (2009) 0.83

Associations between two genetic variants in NKX2-5 and risk of congenital heart disease in Chinese population: a meta-analysis. PLoS One (2013) 0.81

Single-nucleotide polymorphisms of NKX2.5 found in congenital heart disease patients of Mysore, South India. Genet Test Mol Biomarkers (2010) 0.79

[Mutation of NKX2-5 gene in patients with atrial septal defect]. Zhonghua Er Ke Za Zhi (2009) 0.78

Genetic variations of NKX2-5 in sporadic atrial septal defect and ventricular septal defect in Chinese Yunnan population. Gene (2015) 0.77

[Novel NKX2-5 mutations identified in patients with congenital ventricular septal defects]. Zhonghua Yi Xue Za Zhi (2009) 0.77

Investigation of NKX2.5 Gene Mutations in Congenital Heart Defects in an Indian Population. Genet Test Mol Biomarkers (2015) 0.76